March 26, 2017
Recommended Topic Related To:

Theophylline in 5% Dextrose

"The US Food and Drug Administration (FDA) has approved the first long-acting muscarinic antagonist/long-acting beta-2 agonist combination in a pressurized metered-dose inhaler (pMDI), using novel co-suspension technology for chronic obstructive p"...


Theophylline 5% Dextrose Injection Excel

Theophylline in 5% Dextrose Injections USP (theophylline in dextrose excel container)
Excel Container

Do not admix with other drugs.


Theophylline in 5% Dextrose Injections USP (theophylline in dextrose excel container) are sterile, nonpyrogenic solutions intended for intravenous administration, prepared from theophylline and dextrose in Water for Injection USP.

Composition - Each 100 mL contains

Solution Anhydrous Theophylline USP Hydrous Dextrose USP pH Calculated Osmolarity mOsmol/liter
0.08% Theophylline in 5% Dextrose Injection USP 80 mg 5 g 4.7 (3.5-6.5) 255
0.16% Theophylline in 5% Dextrose Injection USP 160 mg 5 g 4.7 (3.5-6.5) 260

Water for Injection USP, qs

Theophylline is structurally classified as a methylxanthine. It occurs as a white, odorless, crystalline powder with a bitter taste. Anhydrous theophylline has the chemical name 1H-Purine-2, 6-dione, 3,7-dihydro-1, 3-dimethyl-, and is represented by the following structural formula:

The formulas of the active ingredients are:

Anhydrous theophylline Structural Formula Illustration

Theophylline, Anhydrous, USP

Hydrous Dextrose Structural Formula Illustration

Hydrous Dextrose USP

The molecular formula of anhydrous theophylline is C7H8N4O2 with a molecular weight of 180.17. The molecular formula of hydrous dextrose is C6H12O6•H2O with a molecular weight of 198.17.

The EXCEL Container is Latex-free; PVC-free; and DEHP-free.

The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.

The closure system has two ports; the one for the administration set has a tamper evident plastic protector. Refer to the Directions for Use of the container.

Last reviewed on RxList: 8/28/2008
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.

Related Drugs
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations